PetIQ Inc (PETQ)
PetIQ Market Cap: 589.52M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 589.52M |
May 16, 2024 | 584.80M |
May 15, 2024 | 578.89M |
May 14, 2024 | 577.71M |
May 13, 2024 | 573.87M |
May 10, 2024 | 544.35M |
May 09, 2024 | 551.73M |
May 08, 2024 | 521.03M |
May 07, 2024 | 518.97M |
May 06, 2024 | 521.03M |
May 03, 2024 | 503.03M |
May 02, 2024 | 497.12M |
May 01, 2024 | 498.01M |
April 30, 2024 | 481.17M |
April 29, 2024 | 484.11M |
April 26, 2024 | 487.36M |
April 25, 2024 | 481.17M |
April 24, 2024 | 487.36M |
April 23, 2024 | 489.42M |
April 22, 2024 | 486.77M |
April 19, 2024 | 479.99M |
April 18, 2024 | 472.62M |
April 17, 2024 | 469.67M |
April 16, 2024 | 477.63M |
April 15, 2024 | 477.04M |
Date | Value |
---|---|
April 12, 2024 | 485.29M |
April 11, 2024 | 509.85M |
April 10, 2024 | 522.81M |
April 09, 2024 | 534.88M |
April 08, 2024 | 536.95M |
April 05, 2024 | 541.66M |
April 04, 2024 | 546.67M |
April 03, 2024 | 551.08M |
April 02, 2024 | 537.24M |
April 01, 2024 | 544.60M |
March 28, 2024 | 533.77M |
March 27, 2024 | 509.24M |
March 26, 2024 | 519.46M |
March 25, 2024 | 507.78M |
March 22, 2024 | 510.41M |
March 21, 2024 | 513.92M |
March 20, 2024 | 500.78M |
March 19, 2024 | 502.53M |
March 18, 2024 | 454.35M |
March 15, 2024 | 460.77M |
March 14, 2024 | 454.06M |
March 13, 2024 | 483.84M |
March 12, 2024 | 483.84M |
March 11, 2024 | 479.75M |
March 08, 2024 | 476.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Dynavax Technologies Corp | 1.454B |
Pacira BioSciences Inc | 1.435B |
Supernus Pharmaceuticals Inc | 1.600B |
Esperion Therapeutics Inc | 447.13M |
Deciphera Pharmaceuticals Inc | 2.202B |
Market Cap Related Metrics
PE Ratio | 90.77 |
PS Ratio | 0.552 |
Price to Book Value | 2.499 |
Price to Free Cash Flow | 54.78 |
Price | 19.94 |
Earnings Yield | 1.10% |
Operating PE Ratio | 9.987 |
Normalized PE Ratio | 26.90 |